| DESCRIPTION | - AL-LAZIKANI et al., J. Mol. Biol., (19970000), vol. 273, pages 927 - 948 |
| DESCRIPTION | - ALWING et al., Eur. Respir. J., (19930000), vol. 6, pages 1368 - 1370 |
| DESCRIPTION | - ANGAL et al., Molecular Immunology, (19930000), vol. 30, page 105 |
| DESCRIPTION | - DJUKANOVIC et al., Eur. Respire. J., (20020000), vol. 37, pages 1 S - 2S |
| DESCRIPTION | - DNA Cloning: A Practical Approach, (19850000), vol. I, II |
| DESCRIPTION | - GOODSON, Medical Applications of Controlled Release, (19840000), vol. 2, pages 115 - 138 |
| DESCRIPTION | - HOPKINS et al., Clin. Otolaryngol., (20090000), vol. 34, pages 447 - 454 |
| DESCRIPTION | - JIA et al., J. Allergy Clin. Immunol., (20120000), vol. 130, page 647 |
| DESCRIPTION | - JIA et al., J Allergy Clin Immunol., (20120000), vol. 130, pages 647 - 654 |
| DESCRIPTION | - LANGER, Science, (19900000), vol. 249, pages 1527 - 1533 |
| DESCRIPTION | - LILLY et al., J. Allergy Clin. Immunol., (19990000), vol. 104, pages 786 - 790 |
| DESCRIPTION | - MARECHAL et al., Anticancer Res., (19880000), vol. 8, pages 677 - 680 |
| DESCRIPTION | - MARTIN et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 9268 - 9272 |
| DESCRIPTION | - MORDENTI et al., Pharmaceut. Res., (19910000), vol. 8, page 1351 |
| DESCRIPTION | - POWELL et al., "Compendium of excipients for parenteral formulations", J Pharm Sci Technol, (19980000), vol. 52, pages 238 - 311, XP009119027 |
| DESCRIPTION | - Remington's Pharmaceutical Sciences, Mack Publishing Company |
| DESCRIPTION | - SEFTON, CRC Crit. Ref. Biomed. Eng., (19870000), vol. 14, page 201 |
| DESCRIPTION | - TANG et al., Eur. Respir. J., (20100000), vol. 35, pages 757 - 760 |
| DESCRIPTION | - TAYLOR et al., Nucl. Acids Res., (19920000), vol. 20, pages 6287 - 6295 |
| DESCRIPTION | - WU et al., J. Biol. Chem., (19870000), vol. 262, pages 4429 - 4432 |
| EXAMINATION | - Prazma C M ET AL, "Characterisation of an OCS-dependent severe asthma population treated with mepolizumab", Thorax, GB, vol. 69, no. 12, doi:10.1136/thoraxjnl-2014-205581, ISSN 0040-6376, (20141201), pages 1141 - 1142, URL: https://thorax.bmj.com/content/thoraxjnl/69/12/1141.full.pdf, XP055937222 |
| INTERNATIONAL-SEARCH-REPORT | - Anonymous, "Archive History for NCT02528214", (20171024), URL: https://clinicaltrials.gov/ct2/history/NCT02528214?V_38=View#StudyPageTop, (20181217), XP055535294 [Y] 1-94 * the whole document * |
| INTERNATIONAL-SEARCH-REPORT | - PILAR BARRANCO ET AL, "Dupilumab in the management of moderate-to-severe asthma: the data so far", THERAPEUTICS AND CLINICAL RISK MANAGEMENT, (20170901), Volume 13, doi:10.2147/TCRM.S125964, pages 1139 - 1149, XP055534125 [Y] 1-94 * the whole document * * page 1143, column r, paragraph 2 - page 1147, column r, paragraph l * |
| OPPOSITION | - Anonymous, "Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (VENTURE); NCT02528214", ClinicalTrials.gov; NCT02528214, (20171024), ClinicalTrials.gov; NCT02528214, URL: https://clinicaltrials.gov/study/NCT02528214?intr=REGN668&cond=Asthma&rank=9&tab=history&a=38#version-content-panel, XP093199830 |
| OPPOSITION | - Anonymous, "GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION", GLOBAL STRATEGY FOR ASTHMA - GINA reports, (20090101), GLOBAL STRATEGY FOR ASTHMA - GINA reports, URL: https://ginasthma.org/wp-content/uploads/2019/01/2009-GINA.pdf, XP093197881 |
| OPPOSITION | - Anonymous, "GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION", GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION, Global Initiative for Asthma (GINA) Guidelines 2016, (20160101), pages 1 - 151, GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION, URL: https://ginasthma.org/wp-content/uploads/2019/01/2016-GINA.pdf, XP093201231 |
| OPPOSITION | - Anonymous, " International Nonproprietary Names for Proposed Pharmaceutical Substances (INN).Proposed: List 108", WHO Drug Information, (20120101), vol. 26, no. 4, pages 401 - 472, XP093196048 |
| OPPOSITION | - Anonymous, "NCT01000506 Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma (DREAM)", ClinicalTrials.gov, NLM, (20170928), pages 1 - 63, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT01000506?tab=history&a=61#version-content-panel, XP093203661 |
| OPPOSITION | - Anonymous, "NCT03020810 | Dupilumab Compassionate Use Study", ClinicalTrials.gov, NLM, (20180307), pages 1 - 6, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT03020810?cond=NCT03020810&rank=1&tab=history&a=4#version-content-panel, XP093203664 |
| OPPOSITION | - Anonymous, "POCKET GUIDE FOR ASTHMA MANAGEMENT AND PREVENTION (for Adults and Children Older than 5 Years)", Global Initiative For Asthma, (20160101), Global Initiative For Asthma, URL: https://ginasthma.org/wp-content/uploads/2016/05/WMS-GINA-2016-main-Pocket-Guide.pdf, XP093199839 |
| OPPOSITION | - Barnes Peter J., Adcock Ian M, "How Do Corticosteroids Work in Asthma? ", PHYSIOLOGY IN MEDICINE: A SERIES OF ARTICLES LINKING MEDICINE WITH SCIENCE, (20030101), pages 359 - 370, XP093199850 |
| OPPOSITION | - "International Nonproprietary Names for Pharmaceutical Substances (INN) Dénominations communes internationales des Substances pharmaceutiques (DCI)", WHO Drug Information, (20120101), WHO Drug Information, URL: http://www.who.int/medicines/publications/druginformation/issues/PL_108.pdf, XP055084074 |
| OPPOSITION | - Molimard, M. ; Buhl, R. ; Niven, R. ; Le Gros, V. ; Thielen, A. ; Thirlwell, J. ; Maykut, R. ; Peachey, G., "Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data", Respiratory Medicine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20100901), vol. 104, no. 9, ISSN 0954-6111, pages 1381 - 1385, XP027178636 |
| OPPOSITION | - Pollart Susan M, Elward Kurtis S, "Overview of Changes to Asthma Guidelines: Diagnosis and Screening", American Family Physician, (20090501), vol. 79, no. 9, pages 761 - 767, XP093197889 |
| OPPOSITION | - Regeneron, "HIGHLIGHTS OF PRESCRIBING INFORMATION See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 03/2017 FULL PRESCRIBING INFORMATION: CONTENTS 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Dosage 2.2 Important Administration Instructions 2.3 Preparation for Use of DUPIXENT Pre-filled Syringe With Needle Shield 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS", (20170407), URL: https://web.archive.org/web/20170407151633if_/https://www.regeneron.com/sites/default/files/Dupixent_FPI.pdf, (20181213), XP055534130 |
| OPPOSITION | - Bob Rj Mash, Angeni Bheekie, Paul Jones, "Inhaled versus oral steroids for adults with chronic asthma", Cochrane Database of Systematic Reviews, doi:10.1002/14651858.CD002160, XP055636795 |
| OPPOSITION | - Normansell Rebecca, Kew Kayleigh M, Mansour George, "Different oral corticosteroid regimens for acute asthma", Cochrane Database of Systematic Reviews, Wiley Interscience, US, US , (20160513), vol. 2016, no. 5, doi:10.1002/14651858.CD011801.pub2, ISSN 1465-1858, pages 1 - 84, XP093203659 |
| OPPOSITION | - Matt Shirley, "Dupilumab: First Global Approval", Drugs, Adis International Ltd., NZ, NZ , (20170525), vol. 77, no. 10, doi:10.1007/s40265-017-0768-3, ISSN 0012-6667, pages 1115 - 1121, XP009556881 |
| OPPOSITION | - Pavord I D, Korn S, Howarth P, Bleecker E R, Buhl R, Keene O N, Ortega H, Chanez P., "Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20120818), vol. 380, no. 9842, doi:10.1016/S0140-6736(12)60988-X, ISSN 0140-6736, pages 651 - 659, XP002714506 |
| OPPOSITION | - Wenzel Sally; Castro Mario; Corren Jonathan; Maspero Jorge; Wang Lin; Zhang Bingzhi; Pirozzi Gianluca; Sutherland E Rand; Evans Robert R; Joish Vijay N; Eckert Laurent; Graham Neil M H; Stahl Neil; Yancopoulos George D; Louis-Tisserand Mariana; Teper Ariel, "Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20160427), vol. 388, no. 10039, doi:10.1016/S0140-6736(16)30307-5, ISSN 0140-6736, pages 31 - 44, XP029627526 |
| OPPOSITION | - Wenzel Sally, Castro Mario, Corren Jonathan, Maspero Jorge, Wang Lin, Zhang Bingzhi, Pirozzi Gianluca, Sutherland E Rand, Evans Robert R, Joish Vijay N, Eckert Laurent, Graham Neil M H, Stahl Neil, Yancopoulos George D, Louis-Tisserand Mariana, Teper Ariel, "Supplementary appendix: Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20160701), vol. 388, no. 10039, doi:10.1016/S0140-6736(16)30307-5, ISSN 0140-6736, pages 1 - 27, XP093201226 |
| OPPOSITION | - Chung Kian Fan, "Dupilumab: a potential new treatment for severe asthma", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20160427), vol. 388, no. 10039, doi:10.1016/S0140-6736(16)30311-7, ISSN 0140-6736, pages 3 - 4, XP029627527 |
| OPPOSITION | - Eugene R Bleecker, J Mark Fitzgerald, Pascal Chanez, Alberto Papi, Steven F Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoria Werkström, Mitchell Goldman, "Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting &bgr;2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20161001), vol. 388, no. 10056, doi:10.1016/S0140-6736(16)31324-1, ISSN 0140-6736, pages 2115 - 2127, XP055342068 |
| OPPOSITION | - Wechsler Michael E, Et Al, "Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study: Correction to Lancet Respir Med 2022; 10: 650-60 April 5, 2022 ", The Lancet, (20220601), vol. 10, no. 7, doi:10.1016/S2213-, page e72, XP093201092 |
| OPPOSITION | - Bernstein Jonathan A. et al, "Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials", The Lancet Respiratory Medicine, Elsevier, (20200501), vol. 8, no. 5, doi:10.1016/S2213-2600(19)30372-8, ISSN 2213-2600, pages 461 - 474, XP093261716 |
| OPPOSITION | - Wenzel Sally E, "Asthma phenotypes: the evolution from clinical to molecular approaches", Nature Medicine, Nature Publishing Group US, New York, New York, (20120501), vol. 18, no. 5, doi:10.1038/nm.2678, ISSN 1078-8956, pages 716 - 725, XP055944372 |
| OPPOSITION | - Wenzel Sally; Ford Linda; Pearlman David; Spector Sheldon; Sher Lawrence; Skobieranda Franck; Wang Lin; Kirkesseli Stephane; Rocklin Ross; Bock Brian; Hamilton Jennifer; Ming Jeffrey E; Radin Allen; Stahl Neil; Yancopoulos George D; Graham Neil; Pirozzi Gianluca, "Dupilumab in Persistent Asthma with Elevated Eosinophil Levels", The New England journal of medicine, Massachusetts Medical Society, US, US , (20130627), vol. 368, no. 26, doi:10.1056/NEJMoa1304048, ISSN 0028-4793, pages 2455 - 2466, XP008165248 |
| OPPOSITION | - Hector G. Ortega, Mark C. Liu, Ian D. Pavord, Guy G. Brusselle, J. Mark Fitzgerald, Alfredo Chetta, Marc Humbert, Lynn E. Katz, Oliver N. Keene, Steven W. Yancey, Pascal Chanez, "Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20140925), vol. 371, no. 13, doi:10.1056/NEJMoa1403290, ISSN 0028-4793, pages 1198 - 1207, XP055317697 |
| OPPOSITION | - Elisabeth H. Bel, Sally E. Wenzel, Philip J. Thompson, Charlene M. Prazma, Oliver N. Keene, Steven W. Yancey, Hector G. Ortega, Ian D. Pavord, "Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20140925), vol. 371, no. 13, doi:10.1056/NEJMoa1403291, ISSN 0028-4793, pages 1189 - 1197, XP055317701 |
| OPPOSITION | - Nair Parameswaran, Wenzel Sally, Rabe Klaus F., Bourdin Arnaud, Lugogo Njira L., Kuna Piotr, Barker Peter, Sproule Stephanie, Ponnarambil Sandhia, Goldman Mitchell, "Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20170622), vol. 376, no. 25, doi:10.1056/NEJMoa1703501, ISSN 0028-4793, pages 2448 - 2458, XP093199832 |
| OPPOSITION | - Rabe Klaus F., Nair Parameswaran, Brusselle Guy, Maspero Jorge F., Castro Mario, Sher Lawrence, Zhu Hongjie, Hamilton Jennifer D., Swanson Brian N., Khan Asif, Chao Jingdong, Staudinger Heribert, Pirozzi Gianluca, Antoni Christian, Amin Nikhil, Ruddy Marcella, Akinlade Bolanle, Graham Neil M.H., Stahl Neil, Yancopoulos George D., Teper Ariel, "Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20180628), vol. 378, no. 26, doi:10.1056/NEJMoa1804093, ISSN 0028-4793, pages 2475 - 2485, XP093201210 |
| OPPOSITION | - Rabe Klaus F., Nair Parameswaran, Brusselle Guy, Maspero Jorge F., Castro Mario, Sher Lawrence, Zhu Hongjie, Hamilton Jennifer D., Swanson Brian N., Khan Asif, Chao Jingdong, Staudinger Heribert, Pirozzi Gianluca, Antoni Christian, Amin Nikhil, Ruddy Marcella, Akinlade Bolanle, Graham Neil M.H., Stahl Neil, Yancopoulos George D., Teper Ariel, "Protocol for: Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20180628), vol. 378, no. 26, doi:10.1056/NEJMoa1804093, ISSN 0028-4793, pages 1 - 321, XP093201220 |
| OPPOSITION | - Rabe Klaus F., Nair Parameswaran, Brusselle Guy, Maspero Jorge F., Castro Mario, Sher Lawrence, Zhu Hongjie, Hamilton Jennifer D., Swanson Brian N., Khan Asif, Chao Jingdong, Staudinger Heribert, Pirozzi Gianluca, Antoni Christian, Amin Nikhil, Ruddy Marcella, Akinlade Bolanle, Graham Neil M.H., Stahl Neil, Yancopoulos George D., Teper Ariel, "Supplementary Appendix: Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20180628), vol. 378, no. 26, doi:10.1056/NEJMoa1804093, ISSN 0028-4793, pages 1 - 34, XP093203202 |
| OPPOSITION | - Al-Ramli Wisam, Al Samri Mohamed, Hamid Qutayba, "TH-17 Cell-Related Cytokines' Potential Role in the Pathogenesis of Severe Asthma", JOURNAL OF ASTHMA, ASTHMA PUBLICATIONS SOCIETY, OSSINING, NY., US, US , (20080101), vol. 45, no. sup1, doi:10.1080/02770900802594759, ISSN 0277-0903, pages 41 - 44, XP093198002 |
| OPPOSITION | - Santini Giuseppe, Mores Nadia, Malerba Mario, Mondino Chiara, Anzivino Roberta, Macis Giuseppe, Montuschi Paolo, "Dupilumab for the treatment of asthma", Expert Opinion on Investigational Drugs, Informa Healthcare, UK, UK , (20170304), vol. 26, no. 3, doi:10.1080/13543784.2017.1282458, ISSN 1354-3784, pages 357 - 366, XP093201249 |
| OPPOSITION | - Pelaia Corrado, Vatrella Alessandro, Gallelli Luca, Terracciano Rosa, Navalesi Paolo, Maselli Rosario, Pelaia Girolamo, "Dupilumab for the treatment of asthma", EXPERT OPINION ON BIOLOGICAL THERAPY, Informa Healthcare, (20171202), vol. 17, no. 12, doi:10.1080/14712598.2017.1387245, ISSN 1471-2598, pages 1565 - 1572, XP093201252 |
| OPPOSITION | - Brodlie Malcolm, Mckean Michael C, Moss Samantha, Spencer David A, "The oral corticosteroid-sparing effect of omalizumab in children with severe asthma", Archives of Disease in Childhood, BMJ Group, (20120701), vol. 97, no. 7, doi:10.1136/archdischild-2011-301570, ISSN 0003-9888, pages 604 - 609, XP093199858 |
| OPPOSITION | - Schellenberg Robert, Adachi Jonathan D R, Bowie Dennis, Brown Jacques, Guenther Lyn, Kader Tina, Trope Graham E, "Oral Corticosteroids in Asthma: A Review of Benefits and Risks", CANADIAN RESPIRATORY JOURNAL, PULSUS GROUP, OAKVILLE, CA, CA , (20070101), vol. 14, no. C, doi:10.1155/2007/160691, ISSN 1198-2241, XP093199845 |
| OPPOSITION | - Wenzel Sally, "Severe Asthma in Adults", American Thoracic Society 2020 International Conference; May 15-20, 2020, American Thoracic Society, (20050715), vol. 172, no. 2, doi:10.1164/rccm.200409-1181PP, ISSN 1073-449X, pages 149 - 160, XP055944998 |
| OPPOSITION | - Haldar Pranab, Pavord Ian D., Shaw Dominic E., Berry Michael A., Thomas Michael, Brightling Christopher E., Wardlaw Andrew J., Green Ruth H., "Cluster Analysis and Clinical Asthma Phenotypes", American Thoracic Society 2020 International Conference; May 15-20, 2020, American Thoracic Society, (20080801), vol. 178, no. 3, doi:10.1164/rccm.200711-1754OC, ISSN 1073-449X, pages 218 - 224, XP093203526 |
| OPPOSITION | - P. G. Woodruff, B. Modrek, D. F. Choy, G. Jia, A. R. Abbas, A. Ellwanger, J. R. Arron, L. L. Koth, J. V. Fahy, "T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma", American Journal of Respiratory and Critical Care Medicine, (20090901), vol. 180, no. 5, doi:10.1164/rccm.200903-0392OC, ISSN 1073449X, pages 388 - 395, XP055049862 |
| OPPOSITION | - Dweik Raed A., Boggs Peter B., Erzurum Serpil C., Irvin Charles G., Leigh Margaret W., Lundberg Jon O., Olin Anna-Carin, Plummer Alan L., Taylor D. Robin, "An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications", American Thoracic Society 2020 International Conference; May 15-20, 2020, American Thoracic Society, (20110901), vol. 184, no. 5, doi:10.1164/rccm.9120-11ST, ISSN 1073-449X, pages 602 - 615, XP093196052 |
| OPPOSITION | - Ray Anuradha, Raundhal Mahesh, Oriss Timothy B., Ray Prabir, Wenzel Sally E., "Current concepts of severe asthma", Journal of Clinical Investigation, American Society for Clinical Investigation, (20160701), vol. 126, no. 7, doi:10.1172/JCI84144, ISSN 0021-9738, pages 2394 - 2403, XP093201516 |
| OPPOSITION | - Bumbacea D., Campbell D., Nguyen L., Carr D., Barnes P.J., Robinson D., Chung K.F., "Parameters associated with persistent airflow obstruction in chronic severe asthma", EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society, GB, GB , (20040701), vol. 24, no. 1, doi:10.1183/09031936.04.00077803, ISSN 0903-1936, pages 122 - 128, XP093198723 |
| OPPOSITION | - Kharitonov S, Alving K, Barnes Pj, "Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force", EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society, GB, GB , (19970701), vol. 10, no. 7, doi:10.1183/09031936.97.10071683, ISSN 0903-1936, pages 1683 - 1693, XP093198760 |
| OPPOSITION | - Busse William W. et al, "Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma", European Respiratory Journal, European Respiratory Society, Leeds, Leeds, (20181030), vol. 53, no. 1800948, doi:10.1183/13993003.00948-2018, ISSN 0903-1936, pages 1 - 11, XP093261723 |
| OPPOSITION | - Austin Daren, Pouliquen Isabelle, Keene Oliver, Yancey Steve, "Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma", 5.3 Allergy and Immunology, European Respiratory Society, (20160901), vol. 48, doi:10.1183/13993003.congress-2016.PA1110, page PA1110, XP009556869 |
| OPPOSITION | - Siergiejko Zenon, Ã… wiebocka Ewa, Smith Nicola, Peckitt Clare, Leo, Peachey Guy, Maykut Robert, "Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients", Current medical research and opinion, Taylor & Francis Group, UK, UK , (20111114), vol. 27, no. 11, doi:10.1185/03007995.2011.620950, ISSN 1473-4877, pages 2223 - 2228, XP009556947 |
| OPPOSITION | - Gert-Jan Braunstahl;Jan Chlumský;Guy Peachey;Chien-Wei Chen , "Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting", Allergy, Asthma & Clinical Immunology, BioMed Central Ltd, London, UK, London, UK , (20131204), vol. 9, no. 1, doi:10.1186/1710-1492-9-47, ISSN 1710-1492, page 47, XP021173227 |
| OPPOSITION | - Luskin Allan, Antonova Evgeniya, Broder Michael, Chang Eunice, Omachi Theodore, Ledford Dennis, "Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis", ClinicoEconomics and Outcomes Research, Volume 8, doi:10.2147/CEOR.S115025, ISSN 1178-6981, pages 641 - 648, XP093199847 |
| OPPOSITION | - Lin Ching-Hsiung , Shih-Lung Cheng, "A review of omalizumab for the management of severe asthma", Drug Design, Development and Therapy, Dove Medical Press Ltd., United Kingdom, United Kingdom , Volume 10, doi:10.2147/DDDT.S112208, ISSN 1177-8881, pages 2369 - 2378, XP093199848 |
| OPPOSITION | - Pilar Barranco, Elsa Phillips-Angles, Javier Dominguez-Ortega, Santiago Quirce, "Dupilumab in the management of moderate-to-severe asthma: the data so far", THERAPEUTICS AND CLINICAL RISK MANAGEMENT, DOVE MEDICAL PRESS LTD.,, NZ, NZ , vol. 13, doi:10.2147/TCRM.S125964, ISSN 1176-6336, pages 1139 - 1149, XP055534125 |
| OPPOSITION | - Pilar Barranco, Elsa Phillips-Angles, Javier Dominguez-Ortega, Santiago Quirce, "Dupilumab in the management of moderate-to-severe asthma: the data so far", Therapeutics and Clinical Risk Management, Volume 13, doi:10.2147/TCRM.S125964, pages 1139 - 1149, XP055534125 |
| OPPOSITION | - Nguyen Vivi, Ulrik Charlotte, "Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma", ALLERGY PROCEEDINGS., OCEAN SIDE PUBLICATIONS, PROVIDENCE, RI., US, US , (20161101), vol. 37, no. 6, doi:10.2500/aap.2016.37.4004, ISSN 1046-9354, pages 125 - 139, XP009556946 |
| OPPOSITION | - Miskoff Jeffrey A, Dewan Asa, Chaudhri Moiuz, "Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome", Cureus, Cureus Inc., US, US , (20190610), vol. 11, no. 6, doi:10.7759/cureus.4864, ISSN 2168-8184, pages e4864 - 8, XP093054662 |
